Lv11
50 积分 2025-03-13 加入
The efficacy and safety of rituximab in adult patients with steroid-dependent or frequent relapsing nephrotic syndrome: A retrospective study
4小时前
已完结
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
24天前
已完结
What Are Baskets, Umbrellas, and Platforms Doing in Nephrology Clinical Trials?
2个月前
已关闭
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
3个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
3个月前
已完结
Rituximab, tacrolimus, cyclophosphamide and cyclosporin in primary membranous nephropathy with nephrotic syndrome: comparison of safety profiles, effect on remission rate, 24-h urinary total protein, serum albumin, and serum creatinine levels using network meta-analysis
3个月前
已完结
Recent Advances in the Development of HIPK2 Inhibitors As anti-renal Fibrosis Agents
5个月前
已完结
Mechanisms of kidney fibrosis and routes towards therapy
5个月前
已完结
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
6个月前
已完结
皖公网安备34019202002308
